U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Isolex 300 & 300i Magnetic Cell Selection System
  1. Blood & Blood Products

Isolex 300 & 300i Magnetic Cell Selection System

Isolex 300 & 300i Magnetic Cell Selection System

Product: Isolex 300 & 300i Magnetic Cell Selection System
Applicant: Nexell Therapeutics, Inc., Irvine, CA
PMA number: BP970001 & BP970001 Supplement 01
Indication for Use:

  • Processing autologuous peripheral blood progenitor cell (PBPC) products to obtain a CD 34+ cell enriched population intended for hematopoietic reconstitution after myeloablative therapy in patients with CD 34-negative tumors.

Approval Date: 7/2/99

Product Information

Supporting Documents